SSH - KALAMAZOO — History
CCN 232035 | 3-year financial timeline | COVID resilience: 43/100
🛡️ Public data only — no PHI permitted on this instance.
$13M
Latest Revenue (FY2022)
+6.6%
Revenue CAGR (3yr)
5.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $12M | $12M | $13M | +5.7% | +6.6% |
| Operating Expenses | $10M | $12M | $13M | +3.9% | +12.4% |
| Operating Margin | 14.7% | 3.6% | 5.2% | +45.4% | -40.4% |
| Net Income | $2M | $0M | $1M | +53.7% | -36.5% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 6,374 | 6,409 | 6,463 | +0.8% | +0.7% |
| Medicare Day % | 37% | 35% | 35% | +1.1% | -1.9% |
| Medicaid Day % | 2% | nan% | 0% | +nan% | -64.8% |
COVID Impact & Recovery
Resilience Score: 43/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +13.6% ($12M → $13M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.6%
This Hospital
+7.6%
State Avg
Latest Margin
5.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $14M | 0.5% |
| FY2024 (proj) | $15M | -4.3% |
| FY2025 (proj) | $16M | -9.0% |